Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3016% below fair value

$1.40−0.10 (-6.67%)

Close on Nov 12, 2026Market cap $11.73MP/E –Yield –

Femasys operating margin

Operating margin is operating income as a percentage of revenue.

Femasys's operating margin for the twelve months ending Jun 30, 2026 was -763.9%. For fiscal 2025 it was -767.0%, against -1091.8% the year before. The highest annual figure on record is -668.0% in fiscal 2020.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-767.0%	+324.8
FY2024	Dec 31, 2024	-1091.8%	+261.7
FY2023	Dec 31, 2023	-1353.4%	−391.7
FY2022	Dec 31, 2022	-961.7%	−255.0
FY2021	Dec 31, 2021	-706.7%	−38.7
FY2020	Dec 31, 2020	-668.0%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-1526.7%	−585.6
Q1 FY2026	Mar 31, 2026	-994.0%	+606.1
Q4 FY2025	Dec 31, 2025	-568.3%	+243.7
Q3 FY2025	Sep 30, 2025	-500.9%	+421.5
Q2 FY2025	Jun 30, 2025	-941.1%	+1082.6
Q1 FY2025	Mar 31, 2025	-1600.1%	−323.0
Q4 FY2024	Dec 31, 2024	-812.0%	+1275.9
Q3 FY2024	Sep 30, 2024	-922.4%	+747.8
Q2 FY2024	Jun 30, 2024	-2023.7%	−1107.7
Q1 FY2024	Mar 31, 2024	-1277.1%	−242.4
Q4 FY2023	Dec 31, 2023	-2087.9%	−807.0
Q3 FY2023	Sep 30, 2023	-1670.2%	−790.3
Q2 FY2023	Jun 30, 2023	-916.0%	−38.5
Q1 FY2023	Mar 31, 2023	-1034.6%	−137.7
Q4 FY2022	Dec 31, 2022	-1280.9%	−353.8
Q3 FY2022	Sep 30, 2022	-879.9%	−44.7
Q2 FY2022	Jun 30, 2022	-877.5%	−294.4
Q1 FY2022	Mar 31, 2022	-896.9%	−343.0
Q4 FY2021	Dec 31, 2021	-927.0%	−334.6
Q3 FY2021	Sep 30, 2021	-835.2%	−335.5
Q2 FY2021	Jun 30, 2021	-583.1%	+226.6
Q1 FY2021	Mar 31, 2021	-553.9%	–
Q4 FY2020	Dec 31, 2020	-592.4%	–
Q3 FY2020	Sep 30, 2020	-499.6%	–
Q2 FY2020	Jun 30, 2020	-809.7%	–